BioStock: PHI “It’s the right moment to capitalize on regenerative medicine momentum.”

May 23, 2024
Language flag

Medtech company Phase Holographic Imaging recently secured a loan facility of SEK 7 million. The company has decided to draw the first tranche from that loan — SEK 4.5 million. In a press release, CEO Patrik Eschricht stated that this provides an opportunity to act on the company’s current momentum. BioStock talked to Eschricht to learn more.

Read the full interview with Patrik Eschricht on biostock.se.

This strategic loan enables us to better lay the groundwork for entering the clinical market. We can leverage the current momentum and accelerate our development projects and product-to-market timeline.

Further reading

PHI published a detailed perspective discussing the versatility and potential the Company sees for Quantitative Phase Imaging (QPI) technology in Regenerative Medicine. PHI outlines how QPI will offer enhanced cell quality control in the cell manufacturing process, thereby addressing a central puzzle piece for making cell-based therapies safe, affordable, and accessible for all.

Read about PHI’s vision for QPI technology in Regenerative Medicine

Latest News

Peter Egelberg CEO PHI

Founder and board member subscribes for shares in the ongoing rights issue

Peter Egelberg, founder and Board member of Phase Holographic Imaging PHI AB has notified the Company that he, together with closely related parties, follows Altium SA’s lead by subscribing for shares in the Company’s ongoing fully secured rights issue. The subscription amounts to approximately 300 TSEK.
AndersMansson-web

PHI at Aktieportföljen Live, BioStock and Financial Stockholm

The subscription period in PHI AB’s fully secured rights issue, totalling SEK 64.3 million, is ongoing until 20 December 2024. The Company’s CEO, Anders Månsson, has during the last couple of weeks presented the Company and its future plans. For links to the presentations and the podcast, see below.

Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ) 8 January 2025

The shareholders of Phase Holographic Imaging PHI AB (publ), (“the Company”), reg.no. 556542-7811, are hereby invited to attend the general meeting on 8 January 2025 at 15.00 at the Company´s office at Skiffervägen 48 in Lund.
See All News